Zingiberis rhizoma -based carbon dots alter serum oestradiol and follicle-stimulating hormone levels in female mice
Source abstract
Abstract
-based carbon dots (ZR-CDs), which exert regulatory effects on serum oestradiol and FSH in mice and show impacts on endometrial growth and follicular development that potentially affect the ability of female fertility. ZR-CDs were characterized to clarify the microstructure, optical features, and functional group characteristics. It shows that ZR-CDs are spherical carbon nanostructures ranging from 0.97 to 2.3 nm in diameter, with fluorescent properties and a surface rich in functional groups. We further investigated the impact of ZR-CDs on oestradiol and FSH in serum, growth, and the development of ovarian and uterine using normal female mice and exogenous oestradiol intervention model. It was observed that ZR-CDs accelerated oestrogen metabolism and attenuated oestradiol-induced endometrial hyperplasia. Simultaneously, ZR-CDs triggered an increase in FSH, even in the presence of high-serum oestradiol that inhibits FSH secretion. Our findings suggest that ZR-CDs could be a potential therapeutic treatment for anovulatory menstruation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Reproductive System and Pregnancy · Selenium in Biological Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China
School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
Centre of Scientific Experiment, Beijing University of Chinese Medicine, Beijing, China
Funding
the Special Funds for Fundamental Research Funds of institutions of higher-learning affiliated with central departments
References (46)
Show source-provided references
1. 10.1056/NEJMoa03006410.1056/NEJMoa030064 ↗
2. 10.1038/s41586-021-04010-310.1038/s41586-021-04010-3 ↗
3. 10.1093/humupd/dmm00910.1093/humupd/dmm009 ↗
4. 10.1530/rep.0.122021510.1530/rep.0.1220215 ↗
5. 10.1016/j.mce.2022.11166210.1016/j.mce.2022.111662 ↗
6. 10.1074/jbc.M115.70536810.1074/jbc.M115.705368 ↗
7. 10.1210/endo-129-3-145210.1210/endo-129-3-1452 ↗
8. 10.1080/21691401.2017.137901510.1080/21691401.2017.1379015 ↗
9. 10.1186/s12951-017-0296-z10.1186/s12951-017-0296-z ↗
10. 10.1016/j.mce.2007.11.02010.1016/j.mce.2007.11.020 ↗
11. 10.1155/2020/469050410.1155/2020/4690504 ↗
12. 10.1210/en.2017-0037410.1210/en.2017-00374 ↗
13. 10.2147/IJN.S17072310.2147/IJN.S170723 ↗
14. Niu YF, Wen P, Li LL, et al. Study on the related substances and channel tropism of baked ginger on warming meridian and hemostasis based on ‘syndrome-efficacy-analysis of biological Samples’. China Journal of Traditional Chinese Medicine and Pharmacy. 2020;35(3):1454–1461.
15. 10.1002/ptr.523510.1002/ptr.5235 ↗
16. Su JB, Zhu QH, Xue XY, et al. Serum metabolism study of the warming channel and hemostatic effect of zingiberis hizome carbonisata. Chinese Traditional and Herbal Drugs. 2015;28(6):1177–1179.
17. 10.1186/s12951-021-00847-y10.1186/s12951-021-00847-y ↗
18. 10.2217/nnm-2018-028510.2217/nnm-2018-0285 ↗
19. 10.1002/bip.2104710.1002/bip.21047 ↗
20. 10.1039/c2cc34612e10.1039/c2cc34612e ↗
21. 10.1021/acsami.9b0007410.1021/acsami.9b00074 ↗
22. 10.1016/j.apsusc.2017.05.25210.1016/j.apsusc.2017.05.252 ↗
23. 10.1039/c2jm16931b10.1039/c2jm16931b ↗
24. 10.1016/j.snb.2017.03.12310.1016/j.snb.2017.03.123 ↗
25. 10.1038/nature0320610.1038/nature03206 ↗
26. 10.1210/mend.15.3.060310.1210/mend.15.3.0603 ↗
27. 10.1095/biolreprod57.5.99010.1095/biolreprod57.5.990 ↗
28. 10.1111/j.1365-2605.2007.00865.x10.1111/j.1365-2605.2007.00865.x ↗
29. 10.1262/jrd.2024110.1262/jrd.20241 ↗
30. 10.1016/j.jhazmat.2012.08.04910.1016/j.jhazmat.2012.08.049 ↗
31. 10.1038/srep2379010.1038/srep23790 ↗
32. 10.1111/j.2042-7158.1960.tb12667.x10.1111/j.2042-7158.1960.tb12667.x ↗
33. 10.1093/jnci/djr47510.1093/jnci/djr475 ↗
34. 10.1016/j.biopha.2018.08.10010.1016/j.biopha.2018.08.100 ↗
35. 10.2217/nnm-2019-036910.2217/nnm-2019-0369 ↗
36. 10.1016/j.steroids.2008.01.01710.1016/j.steroids.2008.01.017 ↗
37. Estradiol/progesterone (bijuva) for menopausal vasomotor symptoms (reprinted from medical letter on drugs and therapeutics, vol 61, pg 99-101, 2019). Jama-J Am Med Assoc. 2019;322(12):1206–1207.
38. 10.1001/jamapsychiatry.2018.061510.1001/jamapsychiatry.2018.0615 ↗
39. 10.1016/j.tem.2018.01.00710.1016/j.tem.2018.01.007 ↗
40. 10.1093/humupd/dmw02710.1093/humupd/dmw027 ↗
41. 10.1038/cdd.2014.12210.1038/cdd.2014.122 ↗
42. 10.1007/s11154-012-9221-910.1007/s11154-012-9221-9 ↗
43. 10.2147/IJN.S7259310.2147/IJN.S72593 ↗
44. 10.1093/oxfordjournals.humrep.a13848010.1093/oxfordjournals.humrep.a138480 ↗
45. 10.1111/j.1365-2265.1993.tb02376.x10.1111/j.1365-2265.1993.tb02376.x ↗
46. 10.1002/uog.1893310.1002/uog.18933 ↗